A multicenter and prospective study of multidisciplinary treatment including surgical lung resection for cN0 non-small cell lung cancer patients with synchronous single organ oligometastasis (ILO 1503)
Phase 2
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000021637
- Lead Sponsor
- International Lung-clinical-Research Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Active other malingant tumor HBV, HCV, HIV Fever up over 38 degree Having steroid therapy Bilateral adrenal metastases, bilateral renal metastases, bone metastases M1a (contralateral lung metastases, malignant pleural effusion, malignant pericardial effusion, pleural dissemination) Other conditions not suitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year overall survival rate
- Secondary Outcome Measures
Name Time Method 2-year disease-free survival rate, 5-year overall survival rate, 5-year disease-free survival rate, adverse event, site of relapse